Related Experiment Video
Updated: Jul 26, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Identifying medically relevant xenon protein targets by in silico screening of the structural proteome
David A Winkler1, Ira Katz2, Andrew Warden3
1Monash Institute of Pharmaceutical Sciences, Monash University, Parkville; Latrobe Institute for Molecular Science, La Trobe University, Bundoora, Australia; School of Pharmacy, University of Nottingham, Nottingham, UK.
Abstract:
In a previous study, in silico screening of the binding of almost all proteins in the Protein Data Bank to each of the five noble gases xenon, krypton, argon, neon, and helium was reported. This massive and rich data set requires analysis to identify the gas-protein interactions that have the best binding strengths, those where the binding of the noble gas occurs at a site that can modulate the function of the protein, and where this modulation might generate clinically relevant effects. Here, we report a preliminary analysis of this data set using a rational, heuristic score based on binding strength and location. We report a partial prioritized list of xenon protein targets and describe how these data can be analyzed, using arginase and carbonic anhydrase as examples. Our aim is to make the scientific community aware of this massive, rich data set and how it can be analyzed to accelerate future discoveries of xenon-induced biological activity and, ultimately, the development of new "atomic" drugs.

